As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

Albert Bourla, the CEO of pharmaceutical company Pfizer ($PFE), plans to meet with activist investor Starboard Value in ...

Real-time index price for TSX REIT Capped Index (RTRE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Bourla and Shantanu Narayen, Pfizer's lead independent director and Adobe Systems CEO, will hold talks with Starboard chief ...

Pfizer CEO is set to meet with activist investor Starboard Value after the investor acquired a $1 billion stake in the ...

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...

Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist ...

Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing ...

PFE obtains $1 billion from activist investor Starboard Value. Stock gains on hopes of a plausible turnaround of the ...

Pfizer Inc.'s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug company. Bondholders seem to like the news too. Spreads on the company's ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Activist investor Starboard Value may not be able to do much to help Pfizer Inc. (NYSE:PFE), according to a Wells Fargo ...